EBR Systems, Inc.
EBR Systems, Inc.
Your view on EBR.AX
Overview
What the company does, where it operates, and who runs it.
About EBR Systems, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- John Graham McCutcheon
- Headquarters
- 480 Oakmead Parkway, Sunnyvale, CA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- John Graham McCutcheon
- Headquarters
- 480 Oakmead Parkway, Sunnyvale, CA, US
EBR Systems, Inc. is a company focused on creating implantable medical devices that employ wireless technology for tissue stimulation. Their flagship product is the WiSE cardiac resynchronization therapy system, which utilizes a unique wireless method to deliver pacing signals directly inside the left ventricle of the heart.
This innovative approach helps overcome the typical challenges linked to traditional pacing leads, including complex insertion, inadvertent nerve activation, displacement, removal procedures, and subsequent adjustments. Established in 2003, the company operates out of Sunnyvale, California.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for EBR Systems, Inc.. Starting points for EBR Systems, Inc.: EPS -AUD 0.08, beta 0.55 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for EBR Systems, Inc.. EBR Systems, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for EBR Systems, Inc.. Trailing twelve-month EPS for EBR Systems, Inc. stands at -AUD 0.08. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | −$0.05 | −$0.06 | −$0.52 | −$0.47 |
| Low estimate | −$0.05 | −$0.06 | −$0.69 | −$0.75 |
| High estimate | −$0.05 | −$0.06 | −$0.36 | −$0.18 |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago EPS | −$0.04 | −$0.521 | −$0.12 | — |
| Growth | −25.9% | — | −337.0% | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $7.30M | $11.32M | $15.71M | $35.85M |
| Low estimate | $7.30M | $11.32M | $15.09M | $28.44M |
| High estimate | $7.30M | $11.32M | $16.40M | $40.53M |
| No. of analysts | 1 | 1 | 3 | 4 |
| Year-ago revenue | $950650.00 | $2.34M | $1.67M | — |
| Growth | +667.6% | +383.6% | +838.9% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for EBR Systems, Inc.. EBR Systems, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AVR.AXAnteris Technologies Ltd | Healthcare | Medical - Devices | — | ||
| CYC.AXCyclopharm Limited | Healthcare | Medical - Devices | — | ||
| IMR.AXImricor Medical Systems, Inc. | Healthcare | Medical - Specialties | — | ||
| IPD.AXImpediMed Limited | Healthcare | Medical - Devices | — | ||
| PNV.AXPolyNovo Limited | Healthcare | Medical - Devices | — | ||
| SOM.AXSomnoMed Limited | Healthcare | Medical - Devices | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BVSBioventus Inc. | Healthcare | NASDAQ | $727.2M | ||
| CALZFPolyNovo Limited | Healthcare | OTC | $472.9M | ||
| CARLCARLSMED, INC. | Healthcare | NASDAQ | $476.0M | ||
| CATXPerspective Therapeutics, Inc. | Healthcare | AMEX | $94.2M | ||
| CBL.AXControl Bionics Limited | Healthcare | ASX | — | ||
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for EBR Systems, Inc.. Coverage tracks EBR Systems, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of EBR Systems, Inc.